Showing results (2071-2080 of 2,098) with videos related to
Sort By:
Pageof 210
Journal of the National Comprehensive Cancer Network : JNCCN|August 16, 2013
Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelinesDavid G Pfister, Kie-Kian Ang, David M Brizel, et al.AJR. American Journal of Roentgenology|August 7, 2020
Multicenter Multireader Evaluation of an Artificial Intelligence-Based Attention Mapping System for the Detection of Prostate Cancer With Multiparametric MRISherif Mehralivand, Stephanie A Harmon, Joanna H Shih, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 15, 2014
Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncologyDavid G Pfister, Sharon Spencer, David M Brizel, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2022
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022Jimmy J Caudell, Maura L Gillison, Ellie Maghami, et al.Orphanet Journal of Rare Diseases|January 27, 2018
International practices in the dietary management of fructose 1-6 biphosphatase deficiencyA Pinto, M Alfadhel, R Akroyd, et al.Journal of Investigational Allergology & Clinical Immunology|July 12, 2014
Severe combined immunodeficiency in Brazil: management, prognosis, and BCG-associated complicationsJ T L Mazzucchelli, C Bonfim, G G Castro, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 8, 2020
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyDavid G Pfister, Sharon Spencer, David Adelstein, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2025
NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025A Dimitrios Colevas, Anthony J Cmelak, David G Pfister, et al.Brain : a Journal of Neurology|December 14, 2020
Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndromeStephen Keddie, Julia Pakpoor, Christina Mousele, et al.The Lancet. Oncology|June 14, 2015
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA TrialsAimée R Kreimer, Frank Struyf, Maria Rowena Del Rosario-Raymundo, et al.Pageof 210